Relatlimab
Relatlimab (BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.Relatlimab has a blocking effect, blocking the interaction of LAG-3/MHC II (IC50: 0.67 nM) and LAG-3/FGL1 (IC50: 0.019 nM) . Relatlimab is often used with Nivoluma to treat advanced melanoma.
Product Specifications
CAS Number
1673516-98-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-5662R-FITC 100 µL
Phospho-NFKB p65 (Thr254) Polyclonal Antibody, FITC Conjugated
Sign In for Pricing
View Details 
orb2658547-01 20 µg
Recombinant Human BPI fold-containing family A member 3 (BPIFA3)
Sign In for Pricing
View Details orb2658547-02 100 µg
Recombinant Human BPI fold-containing family A member 3 (BPIFA3)
Sign In for Pricing
View Details orb2658547-03 1 mg
Recombinant Human BPI fold-containing family A member 3 (BPIFA3)
Sign In for Pricing
View Details